NCT01995656View on ClinicalTrials.gov

A Study of LY3108743 in Healthy Participants and Participants With Type 2 Diabetes

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Placebo - Capsule

Administered orally

DRUG

LY3108743 - Capsule

Administered orally

DRUG

Placebo - Solution

Administered orally

DRUG

LY3108743 - Solution

Administered orally

Trial Locations (1)

117597

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Singapore

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01995656 - A Study of LY3108743 in Healthy Participants and Participants With Type 2 Diabetes | Biotech Hunter | Biotech Hunter